These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24290065)

  • 1. Modeling in vitro inhibition of butyrylcholinesterase using molecular docking, multi-linear regression and artificial neural network approaches.
    Zheng F; Zhan M; Huang X; Abdul Hameed MD; Zhan CG
    Bioorg Med Chem; 2014 Jan; 22(1):538-49. PubMed ID: 24290065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Algorithm and Self-Organizing Maps for QSPR Study of Some N-aryl Derivatives as Butyrylcholinesterase Inhibitors.
    Ahmadi S; Ganji S
    Curr Drug Discov Technol; 2016; 13(4):232-253. PubMed ID: 27457492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.
    Kumar V; De P; Ojha PK; Saha A; Roy K
    Curr Top Med Chem; 2020; 20(18):1601-1627. PubMed ID: 32543359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
    Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of homology model, docking protocol and Machine-Learning based scoring functions for identification of
    Ganeshpurkar A; Singh R; Kumar D; Gutti G; Sardana D; Shivhare S; Singh RB; Kumar A; Singh SK
    J Biomol Struct Dyn; 2022; 40(24):13693-13710. PubMed ID: 34696689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of butyrylcholinesterase inhibitory activity by chlorogenic acids and coffee extracts assed in ITC and docking simulation models.
    Budryn G; Grzelczyk J; Jaśkiewicz A; Żyżelewicz D; Pérez-Sánchez H; Cerón-Carrasco JP
    Food Res Int; 2018 Jul; 109():268-277. PubMed ID: 29803450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
    Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-Aβ Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation.
    Jiang CS; Ge YX; Cheng ZQ; Wang YY; Tao HR; Zhu K; Zhang H
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31311169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.
    Lu X; Yang H; Li Q; Chen Y; Li Q; Zhou Y; Feng F; Liu W; Guo Q; Sun H
    Bioorg Chem; 2019 Apr; 85():117-127. PubMed ID: 30605885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues.
    Gogoi D; Chaliha AK; Sarma D; Kakoti BB; Buragohain AK
    Biomed Pharmacother; 2017 Jan; 85():646-657. PubMed ID: 27903422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.
    Zheng F; McConnell MJ; Zhan CG; Dwoskin LP; Crooks PA
    Bioorg Med Chem; 2009 Jul; 17(13):4477-85. PubMed ID: 19477134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling Auspicious Butyrylcholinesterase Inhibitory Activity of Two Herbal Molecules: Hyperforin and Hyuganin C.
    Orhan IE; Senol Deniz FS; Traedal-Henden S; Cerón-Carrasco JP; den Haan H; Peña-García J; Pérez-Sánchez H; Emerce E; Skalicka-Wozniak K
    Chem Biodivers; 2019 May; 16(5):e1900017. PubMed ID: 30891904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I; Melkemi N; Salah T; Ghalem S
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational redesign of human butyrylcholinesterase for anticocaine medication.
    Pan Y; Gao D; Yang W; Cho H; Yang G; Tai HH; Zhan CG
    Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16656-61. PubMed ID: 16275916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.